Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
354 Cards in this Set
- Front
- Back
Routes of Admin
|
Enteral (via GI/alimentary Tract--Oral; Sublingual, Rectal) or Parenteral (NOT via GI tract--Inhalation; IV; IM; SC; Transdermal, Topical)
Routes of Admin |
|
Anxiolytics/Premed/Morning Cocktail
|
can give w/ narcotic like Fentanyl, but lower dose or will see resp depression
Anxiolytics / Premed / Morning Cocktail Group 1 |
|
Anxiolytics
|
a drug that relieves anxiety.
|| An anxiolytic (antipanic or antianxiety agent) is a drug prescribed for the treatment of symptoms of anxiety. || Some anxiolytics have been shown to be useful in the treatment of anxiety disorders, as have antidepressants such as the class of selective serotonin reuptake inhibitors (SSRIs). |
|
Midazolam
Drug (trade name) |
(Versed)
Anxiolytics / Premed / Morning Cocktail Group 1 |
|
Midazolam
Class |
Benzodiazepine
Anxiolytics / Premed / Morning Cocktail Group 1 |
|
Benzodiazepine
|
a drug belonging to a group of minor tranquilizers.
|| Use: short-term treatment for sleeping difficulties. || Benzodiazepines have varying sedative, hypnotic (sleep-inducing), anxiolytic (anti-anxiety), anticonvulsant, muscle relaxant and amnesic properties. || These properties make benzodiazepines useful in treating anxiety, insomnia, agitation, seizures, muscle spasms, and alcohol withdrawal. || Benzodiazepines vary in their elimination half-life, and are categorized as either short-, intermediate- or long-acting. || Short- and intermediate-acting benzodiazepines are preferred for the treatment of insomnia; longer-acting benzodiazepines are recommended for the treatment of anxiety. |
|
Midazolam
Uses |
Anxiolysis,
Sedation, Amnesia Anxiolytics / Premed / Morning Cocktail Group 1 |
|
Midazolam
[ Supplied ] |
1mg/mL
Anxiolytics / Premed / Morning Cocktail Group 1 |
|
Midazolam
Dosing--card |
1mg
(0.5-2.0) or 0.15-0.3 mg/ kg Anxiolytics / Premed / Morning Cocktail Group 1 |
|
Midazolam
Dosing--Stever |
1-2.5mg
Anxiolytics / Premed / Morning Cocktail Group 1 |
|
Midazolam
Caution |
Hepatic Disease, Elderly, Synergy w/ Narcotics
Anxiolytics / Premed / Morning Cocktail Group 1 |
|
Midazolam
Notes |
Onset 2-5m
Anxiolytics / Premed / Morning Cocktail Group 1 |
|
Induction Drugs
|
very lipid soluble, fast on, fast off, short duration (3-5m), Note propofol/etomidate burn on injection, ketamine has Analgesic effects, and thiopental has a high pH…watch out for crystallization of drug if added w/ acidic drug…instead, push thiopental, flush through into body w/ IV fluid, then do acidic drug
Induction Drugs Group 2 |
|
Propofol
Drug (trade name) |
(Diprivan)
Induction Drugs Group 2 |
|
Propofol
Class |
Diisopropylphenol
Induction Drugs Group 2 |
|
Propofol
Uses |
Induction,
Sedation, MAC Induction Drugs Group 2 |
|
Propofol
[ Supplied ] |
10mg/mL
Induction Drugs Group 2 |
|
Propofol
Dosing--card |
2mg/kg
(1-2.5) Induction Drugs Group 2 |
|
Propofol
Dosing--Stever |
1.5-2.5mg/kg Ind; 25-100mcg/kg/min Inf.
|| Induction Drugs Group 2 |
|
Propofol
Caution |
Bacterial growth, soy/egg allergy
Induction Drugs Group 2 |
|
Propofol
Notes |
Pain on injection, emulsion, elim via redist., ↓ PONV & BP
Induction Drugs Group 2 |
|
Etomidate
Drug (trade name) |
(Amidate)
Induction Drugs Group 2 |
|
Etomidate
Class |
Carboxylated imidazole
Induction Drugs Group 2 |
|
Etomidate
Uses |
Induction, Hypnosis
Induction Drugs Group 2 |
|
Etomidate
[ Supplied ] |
2mg/ml
Induction Drugs Group 2 |
|
Etomidate
Dosing--card |
0.3mg/kg (0.2-0.5)
Induction Drugs Group 2 |
|
Etomidate
Dosing--Stever |
0.2-0.3mg/kg
Induction Drugs Group 2 |
|
Etomidate
Caution |
Pain on injection, Myoclonus, PONV, 35% propylene glycol--BURNS
Induction Drugs Group 2 |
|
Etomidate
Notes |
Induction Drugs
Group 2 |
|
Ketamine
Drug (trade name) |
(Ketalar)
Induction Drugs Group 2 |
|
Ketamine
Class |
Phencyclidine
Induction Drugs Group 2 |
|
Phencyclidine
|
PCP is an arylcyclohexylamine derivative, and, in pharmacology, it is a member of the family of dissociative anesthetics.
|| PCP works primarily as an NMDA receptor antagonist, which blocks the activity of the NMDA receptor.[3] Other NMDA receptor antagonists include ketamine, tiletamine, and dextromethorphan. |
|
Ketamine
Uses |
Induction,
Analgesia, Amnesia Induction Drugs Group 2 |
|
Ketamine
[ Supplied ] |
10, 50, 100 mg/ml
Induction Drugs Group 2 |
|
Ketamine
Dosing--card |
2mg/kg IV
(1-2); 5mg/kg (3-5) IM Induction Drugs Group 2 |
|
Ketamine
Dosing--Stever |
Analgesia 0.2-0.5mg/kg; Induction 1-2mg/kg IV (4-8mg/kg IM)
Induction Drugs Group 2 |
|
Ketamine
Caution |
Emergence Delirium, Drug Interactions-- dec.
amnt inhaled agent needed, potentiates NMB Induction Drugs Group 2 |
|
Ketamine
Notes |
lasts 1 hour, "Special K", deriv.
of PCP Induction Drugs Group 2 |
|
Sodium Thiopental
Drug (trade name) |
Sodium Thiopental
(aka: Sodium Pentothal) Induction Drugs Group 2 |
|
Sodium Thiopental
Class |
Barbiturate
Induction Drugs Group 2 |
|
Barbiturate
|
A drug with sedative and hypnotic properties belonging to a group of derivatives of barbituric acid
|
|
Sodium Thiopental
Uses |
Induction,
cerebral protection Induction Drugs Group 2 |
|
Sodium Thiopental
[ Supplied ] |
2.5%
Induction Drugs Group 2 |
|
Sodium Thiopental
Dosing--card |
4mg/kg (3-6)
Induction Drugs Group 2 |
|
Sodium Thiopental
Dosing--Stever |
3-5 mg/kg
Induction Drugs Group 2 |
|
Sodium Thiopental
Caution |
Drug Interaction (add acidic drug w/ it-->Precip.); Apnea
Induction Drugs Group 2 |
|
Sodium Thiopental
Notes |
Will burn b/c high pH of 10 v.
pH of blood 7.4; Garlic Taste Induction Drugs Group 2 |
|
Neuromuscular Blocking Drugs
|
Paralysis/Muscle Relaxation; Facilitate tracheal intubation, improve surgical working conditions, good for mechanical ventilation of lungs, treat laryngospasm; Classified/chosen according or whether Depolarizing (mimics ACh, binds receptor @ muscle and activates receptor) or Non-depolarizing (binds @ receptor and blocks ACh), duration of action (whether long, intermediate or short acting; duration also affected by liver/kidney disease so keep that in mind), speed of onset, side effects, & pathophysiology; Act by interupting transmission of nerve impulses at NMJ of muscles; review in ppt adverse effects of SUX); Note: Int= Intubation Dose, Inf= Infusion
Neuromuscular Blocking Drugs Group 3 |
|
Neuromuscular Blocking Drugs
|
Neuromuscular-blocking drugs block neuromuscular transmission at the neuromuscular junction, causing paralysis of the affected skeletal muscles.
|| This is accomplished either by acting presynaptically via the inhibition of acetylcholine (ACh) synthesis or release, or by acting postsynaptically at the acetylcholine receptor. || While there are drugs that act presynaptically (such as botulin toxin and tetrodotoxin), the clinically-relevant drugs work postsynaptically. || Clinically, neuromuscular block is used as an adjunct to anesthesia to induce paralysis, so that surgery, especially intra-abdominal and intra-thoracic surgeries, can be carried out with fewer complications. || Because neuromuscular block may paralyze muscles required for breathing, mechanical ventilation should be available to maintain adequate respiration. || Patients are still aware of pain even after full conduction block has occurred; hence, general anesthetics and/or analgesics must be given to prevent anesthesia awareness. |
|
Succinylcholine
Drug (trade name) |
(Anectine)
Neuromuscular Blocking Drugs Group 3 |
|
Succinylcholine
Class |
Depolarizing NMBD
Neuromuscular Blocking Drugs Group 3 |
|
Succinylcholine
Uses |
Intubation, Paralysis, Laryngospasm
Neuromuscular Blocking Drugs Group 3 |
|
Succinylcholine
[ Supplied ] |
20mg/ml
Neuromuscular Blocking Drugs Group 3 |
|
Succinylcholine
Dosing--card |
1mg/kg
(1-1.5) Neuromuscular Blocking Drugs Group 3 |
|
Succinylcholine
Dosing--Stever |
Int same; Laryngospasm 0.1mg/kg IV
Neuromuscular Blocking Drugs Group 3 |
|
Succinylcholine
Caution |
Bradycardia, Hyperalkemia, open globe injury (increases cerebral, intraabdominal and intraoccular pressure)
Neuromuscular Blocking Drugs Group 3 |
|
Succinylcholine
Notes |
Onset: 60sec
Duration: 3-5 min Causes Fasciculations Neuromuscular Blocking Drugs Group 3 |
|
Rocuronium
Drug (trade name) |
(Zemuron)
Neuromuscular Blocking Drugs Group 3 |
|
Rocuronium
Class |
Aminosteroid, ND
Neuromuscular Blocking Drugs Group 3 |
|
Aminosteroid
|
Aminosteroids are a group of drugs with a similar structure based on a steroid nucleus.
Examples are the muscle relaxants rocuronium, vecuronium and pancuronium. |
|
Rocuronium
Uses |
Paralysis, RSI
Neuromuscular Blocking Drugs Group 3 |
|
Rocuronium
[ Supplied ] |
10mg/ml
Neuromuscular Blocking Drugs Group 3 |
|
Rocuronium
Dosing--card |
0.6mg/kg (0.6-1.2)
Neuromuscular Blocking Drugs Group 3 |
|
Rocuronium
Dosing--Stever |
Int same (RSI dose), Maint 0.1mg/kg, Infusion 5-12 mcg/kg/min
Neuromuscular Blocking Drugs Group 3 |
|
Rocuronium
Caution |
Renal failure (b/c excreted via kidneys)
Neuromuscular Blocking Drugs Group 3 |
|
Rocuronium
Notes |
Onset: 1-2 min
Duration: 20-35min Neuromuscular Blocking Drugs Group 3 |
|
Vecuronium
Drug (trade name) |
(Norcuron)
Neuromuscular Blocking Drugs Group 3 |
|
Vecuronium
Class |
Aminosteroid, ND
Neuromuscular Blocking Drugs Group 3 |
|
Vecuronium
Uses |
Paralysis
Neuromuscular Blocking Drugs Group 3 |
|
Vecuronium
[ Supplied ] |
10mg powder vial, reconst.
to 1mg/ml w/ 10cc sdH2O Neuromuscular Blocking Drugs Group 3 |
|
Vecuronium
Dosing--card |
0.1mg/kg (0.08-0.12)
Neuromuscular Blocking Drugs Group 3 |
|
Vecuronium
Dosing--Stever |
Int same, Inf 1-2mcg/kg/min, Maint 0.01mg/kg
Neuromuscular Blocking Drugs Group 3 |
|
Vecuronium
Caution |
Renal/Hepatic Dysfunction(elim.
Via these routes), Peds/ Elderly (larger/smaller dose resp.) Neuromuscular Blocking Drugs Group 3 |
|
Vecuronium
Notes |
onset 3-5 m
Duration: 20-35 min Neuromuscular Blocking Drugs Group 3 |
|
Cisatracurium
Drug (trade name) |
(Nimbex)
Neuromuscular Blocking Drugs Group 3 |
|
Cisatracurium
Class |
Benzyl isoquinolinium, ND
Neuromuscular Blocking Drugs Group 3 |
|
Benzyl isoquinolinium
|
Isoquinolines find many applications, including (but not limited to): anesthetics; dimethisoquin is one example.
vasodilators, a well-known example, papaverine. |
|
Cisatracurium
Uses |
Paralysis
Neuromuscular Blocking Drugs Group 3 |
|
Cisatracurium
[ Supplied ] |
20mg vial (2mg/ml)
Neuromuscular Blocking Drugs Group 3 |
|
Cisatracurium
Dosing--card |
0.1mg/kg (0.1-0.15)
Neuromuscular Blocking Drugs Group 3 |
|
Cisatracurium
Dosing--Stever |
Int same, Inf 1-2mcg/kg/min
Neuromuscular Blocking Drugs Group 3 |
|
Cisatracurium
Caution |
Neuromuscular Blocking Drugs
Group 3 |
|
Cisatracurium
Notes |
Onset: 3-5 min
Duration: 20-35 min Hoffman Elim.,not metab in liver/kidneys, use for pt w/ renal disease Neuromuscular Blocking Drugs Group 3 |
|
Pancuronium
Drug (trade name) |
(Pavulon)
Neuromuscular Blocking Drugs Group 3 |
|
Pancuronium
Class |
Aminosteroid, ND
Neuromuscular Blocking Drugs Group 3 |
|
Pancuronium
Uses |
Paralysis
Neuromuscular Blocking Drugs Group 3 |
|
Pancuronium
[ Supplied ] |
1mg/mL
Neuromuscular Blocking Drugs Group 3 |
|
Pancuronium
Dosing--card |
0.1mg/kg (0.08-0.12)
Neuromuscular Blocking Drugs Group 3 |
|
Pancuronium
Dosing--Stever |
Int same, Mt 0.01mg/kg
Neuromuscular Blocking Drugs Group 3 |
|
Pancuronium
Caution |
↑ HR (tachycardia), MAP, CO; Clearance ↓ up to 50% w/ renal failure
Neuromuscular Blocking Drugs Group 3 |
|
Pancuronium
Notes |
Onset: 3-5 min
Duration: 60-90 min Long duration, Hepatic/Renal Elim. || Neuromuscular Blocking Drugs Group 3 |
|
Atracurium
Drug (trade name) |
(Tracrium)
Neuromuscular Blocking Drugs Group 3 |
|
Atracurium
Class |
Benzyl isoquinolinium, ND
Neuromuscular Blocking Drugs Group 3 |
|
Atracurium
Uses |
Paralysis
Neuromuscular Blocking Drugs Group 3 |
|
Atracurium
[ Supplied ] |
Neuromuscular Blocking Drugs
Group 3 |
|
Atracurium
Dosing--card |
0.5mg/kg (0.3-0.6)
Neuromuscular Blocking Drugs Group 3 |
|
Atracurium
Dosing--Stever |
Neuromuscular Blocking Drugs
Group 3 |
|
Atracurium
Caution |
Neuromuscular Blocking Drugs
Group 3 |
|
Atracurium
Notes |
Onset: 3-5 min; Duration 20-35 min
Neuromuscular Blocking Drugs Group 3 |
|
Opioids/Narcotics
|
Pain Relief; choose based on potency, onset/duration time and method of metabolization (keep byproducts and their toxicity in mind).
|| Opioids / Narcotics Group 4 |
|
Opioids
|
Any opium-containing substance that is produced naturally in the brain.
Similar in effect or properties to opium but not derived from opium. An opioid is a chemical that works by binding to opioid receptors, which are found principally in the central nervous system and the gastrointestinal tract. The receptors in these two organ systems mediate both the beneficial effects and the side effects of opioids. The analgesic (pain relieving) effects of opioids are due to decreased perception of pain, decreased reaction to pain as well as increased pain tolerance. The side effects of opioids include sedation, respiratory depression, and constipation. Opioids can cause cough suppression, which can be both an indication for opioid administration or an unintended side effect. |
|
Narcotics
|
Agents that benumb or deaden, causing loss of feeling or paralysis.
Something that soothes, induces sleep, relieves pain or stress, or causes a sensation of mental numbness. |
|
Morphine
Drug (trade name) |
Morphine
Opioids / Narcotics Group 4 |
|
Morphine
Class |
Natural
Opioids / Narcotics Group 4 |
|
Morphine
Uses |
IV, epidural,
spinal--Pain relief Opioids / Narcotics Group 4 |
|
Morphine
[ Supplied ] |
10mg/ml
Opioids / Narcotics Group 4 |
|
Morphine
Dosing--card |
0.1mg/kg (0.05-0.15)
Opioids / Narcotics Group 4 |
|
Morphine
Dosing--Stever |
Intraop 0.1-1mg/kg IV; Postop 0.03-0.15mg/kg IV
Opioids / Narcotics Group 4 |
|
Morphine
Caution |
Depression of ventilation; PONV, Biliary spasm, Itching, Histamine release
Opioids / Narcotics Group 4 |
|
Morphine
Notes |
IV/IM, low lipid solubility-->slower onset(15-30m), Potency 1, 2-10mg peak effect 45-90m, duration 3-4h, metab.
in liver/kidnerys, active metabolite almost as potent as morphine, so will accumulate & last longer in pt w/ kidney/renal disease. Opioids / Narcotics Group 4 |
|
Fentanyl
Drug (trade name) |
Fentanyl
Opioids / Narcotics Group 4 |
|
Fentanyl
Class |
Synthetic Opioid
Opioids / Narcotics Group 4 |
|
Synthetic Opioid
|
An Opiod made artificially by chemical synthesis, especially so as to resemble a natural product
|
|
Fentanyl
Uses |
Analgesia
Opioids / Narcotics Group 4 |
|
Fentanyl
[ Supplied ] |
50mcg/ml
Opioids / Narcotics Group 4 |
|
Fentanyl
Dosing--card |
1-2mcg/kg premed; 2-5mcg/kg during Ind.
|| Opioids / Narcotics Group 4 |
|
Fentanyl
Dosing--Stever |
low dose 1-2mcg/kg, mod dose 2-20 mcg/kg, Inf 1-2mcg/kg/hr
Opioids / Narcotics Group 4 |
|
Fentanyl
Caution |
75-125x more potent than morphine
Opioids / Narcotics Group 4 |
|
Fentanyl
Notes |
VERY lipid soluble & protein bound, can do IV,transdermal or PO, Peak effect 3-5m, duration 30-60m, 75% undergoes 1st pass pulmonary uptake/metab., Hemodynamic stability(doesn't cause histamine release), Drug interactions (can dec.
inhalation/induction agent dose req'd), can cause postop depression Opioids / Narcotics Group 4 |
|
Meperidine
Drug (trade name) |
(Demerol)
Opioids / Narcotics Group 4 |
|
Meperidine
Class |
synthetic opioid
Opioids / Narcotics Group 4 |
|
Meperidine
Uses |
Analgesia, postop shivering prevention
Opioids / Narcotics Group 4 |
|
Meperidine
[ Supplied ] |
2.5%, 5%, 7.5%, 10%
Opioids / Narcotics Group 4 |
|
Meperidine
Dosing--card |
12.5mg (shivering dose)
Opioids / Narcotics Group 4 |
|
Meperidine
Dosing--Stever |
periop analgesia 75-100mg IV, postop shivering 25mg IV
Opioids / Narcotics Group 4 |
|
Meperidine
Caution |
Neurotoxic(active metab.
Accumulates--> seizures, esp in pt w/ renal disease), Renal Disease; Histamine Release Opioids / Narcotics Group 4 |
|
Meperidine
Notes |
Less potent than morphine (0.1 = potency)
Opioids / Narcotics Group 4 |
|
Hydromorphone
Drug (trade name) |
(Dilaudid)
Opioids / Narcotics Group 4 |
|
Hydromorphone
Class |
Semi-synthetic
Opioids / Narcotics Group 4 |
|
Semi-synthetic
|
"_____" or partial chemical _____ is a type of chemical synthesis that uses compounds isolated from natural sources (e.g.
plant material or bacterial or cell cultures) as starting materials. These natural biomolecules are usually large and complex molecules. This is opposed to a total _____ where large molecules are synthesized from a stepwise combination of small and cheap (petrochemical) building blocks. |
|
Hydromorphone
Uses |
Analgesia
Opioids / Narcotics Group 4 |
|
Hydromorphone
[ Supplied ] |
2mg ampule
Opioids / Narcotics Group 4 |
|
Hydromorphone
Dosing--card |
0.5mg
(0.25-1.0) Opioids / Narcotics Group 4 |
|
Hydromorphone
Dosing--Stever |
0.5-2 mg
Opioids / Narcotics Group 4 |
|
Hydromorphone
Caution |
8x as potent as morphine
Opioids / Narcotics Group 4 |
|
Hydromorphone
Notes |
synth heroine, long-term postop pain relief
Opioids / Narcotics Group 4 |
|
Narcotic Antagonist
|
An opioid antagonist is a receptor antagonist that acts on opioid receptors.
|| A receptor antagonist is a type of receptor ligand or drug that does not provoke a biological response itself upon binding to a receptor, but blocks or dampens agonist-mediated responses.[1] In pharmacology, antagonists have affinity but no efficacy for their cognate receptors, and binding will disrupt the interaction and inhibit the function of an agonist or inverse agonist at receptors. Antagonists mediate their effects by binding to the active site or to allosteric sites on receptors, or they may interact at unique binding sites not normally involved in the biological regulation of the receptor's activity. || Narcotic Antagonist Group 5 |
|
Narcotic Antagonist / Opioid antagonists
|
Drugs which are competitive antagonists that bind to the opioid receptors with higher affinity than agonists but do not activate the receptors.
This effectively blocks the receptor, preventing the body from responding to opiates and endorphins. |
|
Naloxone
Drug (trade name) |
(Narcan)
Narcotic Antagonist Group 5 |
|
Naloxone
Class |
Opioid antagonists
Narcotic Antagonist Group 5 |
|
Naloxone
Uses |
overdose, resp.
depression, REVERSE OPIOID Narcotic Antagonist Group 5 |
|
Naloxone
[ Supplied ] |
0.4 mg vial
Narcotic Antagonist Group 5 |
|
Naloxone
Dosing--card |
20-40-80 mcg (progressive dosing)
Narcotic Antagonist Group 5 |
|
Naloxone
Dosing--Stever |
1-4 mcg/kg
Narcotic Antagonist Group 5 |
|
Naloxone
Caution |
causes N/V, pain, tachycardia, increased SNS output (all b/c taken away analgesia), DILUTE 0.4mg vial in 10mL and give 1-2ml over 2-3 minutes
Narcotic Antagonist Group 5 |
|
Naloxone
Notes |
Quick onset--1min
Narcotic Antagonist Group 5 |
|
Maintenance Drugs
|
Keep pt asleep/Volatile Inhalation Drugs--not on card; note breathing circuit--FGF determined by vaporizer and flowmeter settings, Fi det.
By FGF rate, breathing circuit volume and circuit absorption, FA (alveolar gas [c]) determined by uptake, ventilation, and [c] effect/2nd gas effect, Fa (arterial gas [c]) affected by ventilation/perfusion mismatching; MAC-Minimum Aveolar Concentration, or the [c] of the anesthetic vapor needed to prevent movement in 50% of patients in response to pain/surgical stimulus; MAC allows for comparison of potency, values are additive, 1.3MAC prevents mvmt in 95% of pts, 6% decrease in MAC per decade of age starting in 20s, values listed below are for 50 year olds; Pulmonary System--All volatiles INCREASE RR, DECREASE Tidal Volume-->net effect of decreased Minute Ventilation--> rapid shallow breathing, also Decrease ventilatory response to both hypoxemia and hypercarbia and decrease functional residual capacity (FRC); Note that SEVO has byproduct Compound A--Use high flows (2L/min) and DES has byproduct of Carbon Monoxide; ISO-purple, Des-Blue, Sevo-yellow. SID = mnemonic, most to least metabolized in the liver Maintenance Drugs Group 6 |
|
Maintenance Drugs
|
In pharmacokinetics, a loading dose refers to an initial higher dose of a drug that may be given at the beginning of a course of treatment before dropping down to a lower _____ dose.
A loading dose is most useful for drugs that are eliminated from the body relatively slowly. Such drugs need only a low _____ dose in order to keep the amount of the drug in the body at the appropriate level, but this also means that, without an initial higher dose, it would take a long time for the amount of the drug in the body to reach that level. |
|
Isoflurane
Drug (trade name) |
Isoflurane
Maintenance Drugs Group 6 |
|
Isoflurane
Class |
Maintenance Drugs
Group 6 |
|
Isoflurane
Uses |
Maintenance
Maintenance Drugs Group 6 |
|
Isoflurane
[ Supplied ] |
Maintenance Drugs
Group 6 |
|
Isoflurane
Dosing--card |
N/A
Maintenance Drugs Group 6 |
|
Isoflurane
Dosing--Stever |
MAC 1.1%
Maintenance Drugs Group 6 |
|
Isoflurane
Caution |
Highly Potent, A/W irritant, trickles to fat and prolongs emergence, min metabolism 0.2%(breathe out most of what we just breathed in)
Maintenance Drugs Group 6 |
|
Isoflurane
Notes |
Very stable CV changes-minimal at 1 Mac, smells bad
Maintenance Drugs Group 6 |
|
Desflurane
Drug (trade name) |
Desflurane
Maintenance Drugs Group 6 |
|
Desflurane
Class |
Maintenance Drugs
Group 6 |
|
Desflurane
Uses |
Maintenance
Maintenance Drugs Group 6 |
|
Desflurane
[ Supplied ] |
Maintenance Drugs
Group 6 |
|
Desflurane
Dosing--card |
N/A
Maintenance Drugs Group 6 |
|
Desflurane
Dosing--Stever |
MAC 6.0%
Maintenance Drugs Group 6 |
|
Desflurane
Caution |
Pungent-A/W irritant(avoid w/ reactive airways/pt w/ asthma or smoking history even), Carbon Monoxide formation in CO2 absorber
Maintenance Drugs Group 6 |
|
Desflurane
Notes |
Highly insoluble-prompt recovery/emergence, Easily titratable due to high MAC
Maintenance Drugs Group 6 |
|
Sevoflurane
Drug (trade name) |
Sevoflurane
Maintenance Drugs Group 6 |
|
Sevoflurane
Class |
Maintenance Drugs
Group 6 |
|
Sevoflurane
Uses |
Maintenance
Maintenance Drugs Group 6 |
|
Sevoflurane
[ Supplied ] |
Maintenance Drugs
Group 6 |
|
Sevoflurane
Dosing--card |
N/A
Maintenance Drugs Group 6 |
|
Sevoflurane
Dosing--Stever |
MAC 2.0%
Maintenance Drugs Group 6 |
|
Sevoflurane
Caution |
Compound A formation(use high flows), metabolized 2-5%, renal tubular injury, Prompt Recovery
Maintenance Drugs Group 6 |
|
Sevoflurane
Notes |
sweet smelling, least a/w irritant, used for inhalational inductions, particularly in pediatrics
Maintenance Drugs Group 6 |
|
Nitrous Oxide
Drug (trade name) |
Nitrous Oxide
Maintenance Drugs Group 6 |
|
Nitrous Oxide
Class |
Maintenance Drugs
Group 6 |
|
Nitrous Oxide
Uses |
Maintenance--additive
Maintenance Drugs Group 6 |
|
Nitrous Oxide
[ Supplied ] |
Maintenance Drugs
Group 6 |
|
Nitrous Oxide
Dosing--card |
N/A
Maintenance Drugs Group 6 |
|
Nitrous Oxide
Dosing--Stever |
MAC>100%
Maintenance Drugs Group 6 |
|
Nitrous Oxide
Caution |
Enclosed spaces, Diffusion Hypoxia (can replace O2 in aveoli w/ N20, attenuate w/ O2 through canula/facemask)
Maintenance Drugs Group 6 |
|
Nitrous Oxide
Notes |
Analgesic properties, sweet smelling, easy to breathe, remember ~ hypoxic mixture stuff; decrease amnt of inhaled anesthetic when using N2O b/c MACs additive, ↑ PONV???
Maintenance Drugs Group 6 |
|
Sympathomimetics
|
Uppers; ↑BP; pt's "tubes" not full b/c haven't eaten, dehydrated, etc., if you vasoconstrict you can increase volume compared to size of tube, inserting ETT raises BP b/c it is a strong stimulus, then BP may drop until next stimulus--surgical incision, so may need to use these until then to keep BP at desired/reasonable rate; Divided into Catecholamines & Synthetic Noncatecholamines; work through activation of α (vasculature--vasocontriction), β1 (heart--↑HR) and/or β2 (lungs--brachial relaxation) receptors--remember this w/ mnemonic 1 Heart, 2 lungs for beta receptors
Sympathomimetics Group 7 |
|
Sympathomimetics
|
Describes a drug that stimulates the sympathetic nervous system or produces physiological effects similar to it
|
|
Epinephrine
Drug (trade name) |
Epinephrine
Sympathomimetics Vasoactive Drugs Group 7 |
|
Epinephrine
Class |
Catecholamine
Sympathomimetics Vasoactive Drugs Group 7 |
|
Catecholamine
|
A compound that acts as a neurotransmitter or hormone.
Catecholamines are sympathomimetic "fight-or-flight" hormones that are released by the adrenal glands in response to stress. They are part of the sympathetic nervous system. The most abundant catecholamines are epinephrine (adrenaline), norepinephrine (noradrenaline) and dopamine, all of which are produced from phenylalanine and tyrosine. |
|
Epinephrine
Uses |
↑HR/BP, Anaphylaxis, bronchospam
Sympathomimetics Vasoactive Drugs Group 7 |
|
Epinephrine
[ Supplied ] |
16mcg/ml syringe; 4mcg/ml bag
Sympathomimetics Vasoactive Drugs Group 7 |
|
Epinephrine
Dosing--card |
8mcg (8-16) Dose-i
Sympathomimetics Vasoactive Drugs Group 7 |
|
Epinephrine
Dosing--Stever |
sm dose 1-2mcg/min β2 (lungs/bronchial tubes); med dose 4mcg/min β1 (heart); large dose 10-20 mcg/min α&β(vacular smooth muscle)
Sympathomimetics Vasoactive Drugs Group 7 |
|
Epinephrine
Caution |
Sympathomimetics
Vasoactive Drugs Group 7 |
|
Epinephrine
Notes |
Sympathomimetics
Vasoactive Drugs Group 7 |
|
Ephedrine
Drug (trade name) |
Ephedrine
Sympathomimetics Vasoactive Drugs Group 7 |
|
Ephedrine
Class |
Synthetic non-catecholamine; direct/indirect action
Sympathomimetics Vasoactive Drugs Group 7 |
|
Ephedrine
Uses |
↑HR/BP
Sympathomimetics Vasoactive Drugs Group 7 |
|
Ephedrine
[ Supplied ] |
5mg/ml(from 25 or 50 mg/ 1mL vial)
Sympathomimetics Vasoactive Drugs Group 7 |
|
Ephedrine
Dosing--card |
5mg (5-25) initial dose
Sympathomimetics Vasoactive Drugs Group 7 |
|
Ephedrine
Dosing--Stever |
5-20 mg
Sympathomimetics Vasoactive Drugs Group 7 |
|
Ephedrine
Caution |
Tachyphylaxis (tolerance), depletion of norepinephrine
Sympathomimetics Vasoactive Drugs Group 7 |
|
Ephedrine
Notes |
works @ symp.
N terminal & releases norepinephrine to ↑BP Sympathomimetics Vasoactive Drugs Group 7 |
|
Phenylephrine
Drug (trade name) |
Phenylephrine
Sympathomimetics Vasoactive Drugs Group 7 |
|
Phenylephrine
Class |
Synthetic non-catecholamine; direct action
Sympathomimetics Vasoactive Drugs Group 7 |
|
Phenylephrine
Uses |
↑BP, Nasal decongestant (use w/ insertion of NA)
Sympathomimetics Vasoactive Drugs Group 7 |
|
Phenylephrine
[ Supplied ] |
100mcg/mL
Sympathomimetics Vasoactive Drugs Group 7 |
|
Phenylephrine
Dosing--card |
100mcg (50-200)
Sympathomimetics Vasoactive Drugs Group 7 |
|
Phenylephrine
Dosing--Stever |
Bolus 50-100mcg, Inf 0.25-1 mcg/kg/min
Sympathomimetics Vasoactive Drugs Group 7 |
|
Phenylephrine
Caution |
Increased afterload(heart pumping against high P), Reflex Bradycardia (↑BP but ↓HR)
Sympathomimetics Vasoactive Drugs Group 7 |
|
Phenylephrine
Notes |
binds to α receptors to vasoconstrict "pipe"
Sympathomimetics Vasoactive Drugs Group 7 |
|
Norepinephrine
Drug (trade name) |
Norepinephrine
Sympathomimetics Vasoactive Drugs Group 7 |
|
Norepinephrine
Class |
Sympathomimetics
Vasoactive Drugs Group 7 |
|
Norepinephrine
Uses |
Sympathomimetics
Vasoactive Drugs Group 7 |
|
Norepinephrine
[ Supplied ] |
Sympathomimetics
Vasoactive Drugs Group 7 |
|
Norepinephrine
Dosing--card |
16mcg(8-16)
Sympathomimetics Vasoactive Drugs Group 7 |
|
Norepinephrine
Dosing--Stever |
N/A
Sympathomimetics Vasoactive Drugs Group 7 |
|
Norepinephrine
Caution |
Sympathomimetics
Vasoactive Drugs Group 7 |
|
Norepinephrine
Notes |
Sympathomimetics
Vasoactive Drugs Group 7 |
|
Antihypertensives
|
Downers; ↓BP; β-blockers block β1 receptors to lower HR while Peripheral Vasodialators work against α1 receptors to dialate vasculature and cause a decrease in BP (nitroprusside and nitroglycerin work to relax vascular smooth muscle through Nitrous oxide--N2O)
Antihypertensives Group 8 |
|
Antihypertensives
|
|
|
Esmolol
Drug (trade name) |
Esmolol (Brevibloc)
Antihypertensives Group 8 |
|
Esmolol
Class |
Cardioselective β Blocker
Antihypertensives Group 8 |
|
Cardioselective β Blocker
|
A drug that regulates the activity of the heart.
Use: treatment of high blood pressure. A class of drugs used for various indications, but particularly for the management of cardiac arrhythmias, cardioprotection after myocardial infarction (heart attack), and hypertension. Beta blockers may also be referred to as beta-adrenergic blocking agents, beta-adrenergic antagonists, or beta antagonists. |
|
Esmolol
Uses |
↓ HR
Antihypertensives Group 8 |
|
Esmolol
[ Supplied ] |
100mg (10mg/mL in 10 ml)
Antihypertensives Group 8 |
|
Esmolol
Dosing--card |
5 mg (5-10)
Antihypertensives Group 8 |
|
Esmolol
Dosing--Stever |
0.2-0.5 mg/kg
Antihypertensives Group 8 |
|
Esmolol
Caution |
↓HR/Contractility/BP, CHF (exacerbate pts w/ this); Asthma
Antihypertensives Group 8 |
|
Esmolol
Notes |
Degraded by pseudocholinesterases, so fast off; selective for β1 receptors, Duration minutes
Antihypertensives Group 8 |
|
Metoprolol
Drug (trade name) |
Metoprolol (Lopressor)
Antihypertensives Group 8 |
|
Metoprolol
Class |
β blocker, long acting, selective forβ1recept(heart)
Antihypertensives Group 8 |
|
Metoprolol
Uses |
↓ HR
Antihypertensives Group 8 |
|
Metoprolol
[ Supplied ] |
5mg (1mg/ml)
Antihypertensives Group 8 |
|
Metoprolol
Dosing--card |
N/A
Antihypertensives Group 8 |
|
Metoprolol
Dosing--Stever |
1-2mg
Antihypertensives Group 8 |
|
Metoprolol
Caution |
↓HR/Contractility/BP, CHF (exacerbate pts w/ this); Asthma
Antihypertensives Group 8 |
|
Metoprolol
Notes |
pretty much same as Esmolol but Duration = hours
Antihypertensives Group 8 |
|
Labetolol
Drug (trade name) |
Labetolol (normodyne)
Antihypertensives Group 8 |
|
Labetolol
Class |
Mixed antagonists α1, β1, β2
Antihypertensives Group 8 |
|
Mixed antagonists
|
In the field of pharmacology, a selective receptor modulator or SRM is a type of drug that has different effects in different tissues.
A SRM may behave as an agonist in some tissues while as an antagonist in others. Hence selective receptor modulators are sometimes referred to as tissue selective drugs or mixed agonists / antagonists. This tissue selective behavior is in contrast to many other drugs that behave either as agonists or antagonists regardless of the tissue in question. |
|
Labetolol
Uses |
Control HR & BP
Antihypertensives Group 8 |
|
Labetolol
[ Supplied ] |
5mg/ml (20ml vial)
Antihypertensives Group 8 |
|
Labetolol
Dosing--card |
5mg (5-10)
Antihypertensives Group 8 |
|
Labetolol
Dosing--Stever |
0.1-0.25 mg/kg
Antihypertensives Group 8 |
|
Labetolol
Caution |
Avoid in asthmatic pt--works in lungs
Antihypertensives Group 8 |
|
Labetolol
Notes |
α1 and nonselective β1 & β2 antagonist; β:α = 7:1
Antihypertensives Group 8 |
|
Sodium Nitroprusside
Drug (trade name) |
Sodium Nitroprusside
Antihypertensives Group 8 |
|
Sodium Nitroprusside
Class |
Hypotensive Agent
Antihypertensives Group 8 |
|
Hypotensive Agent
|
An agent that unusually induces low blood pressure.
In physiology and medicine, hypotension refers to an abnormally low blood pressure. This is best understood as a physiologic state, rather than a disease. It is often associated with shock, though not necessarily indicative of it. Hypotension is the opposite of hypertension, which is high blood pressure. Hypotension can be life-threatening. |
|
Sodium Nitroprusside
Uses |
Relax arterial and venous (↓ bld bk to heart and ↓ P it pumps angainst)
Antihypertensives Group 8 |
|
Sodium Nitroprusside
[ Supplied ] |
100mcg/mL
Antihypertensives Group 8 |
|
Sodium Nitroprusside
Dosing--card |
50mcg (25-50)
Antihypertensives Group 8 |
|
Sodium Nitroprusside
Dosing--Stever |
bolus 1-2mcg/kg, Inf 0.5-10 mcg/kg/min
Antihypertensives Group 8 |
|
Sodium Nitroprusside
Caution |
Non-selective (Venous dilation=arterial), cyanide toxicity (byproduct), Methemoglobinemia
Antihypertensives Group 8 |
|
Sodium Nitroprusside
Notes |
short acting; light sensitive
Antihypertensives Group 8 |
|
Nitroglycerin
Drug (trade name) |
Nitroglycerin
Antihypertensives Group 8 |
|
Nitroglycerin
Class |
Hypotensive Agent
Antihypertensives Group 8 |
|
Nitroglycerin
Uses |
Angina, HTN (used to treat)
Antihypertensives Group 8 |
|
Nitroglycerin
[ Supplied ] |
100mcg/mL
Antihypertensives Group 8 |
|
Nitroglycerin
Dosing--card |
50mcg; Bolus 50-100mcg, Inf 0.5-10mcg/kg/min
Antihypertensives Group 8 |
|
Nitroglycerin
Dosing--Stever |
Antihypertensives
Group 8 |
|
Nitroglycerin
Caution |
Principal Venous Dilator, ↓ Ventric Wall Tension
Antihypertensives Group 8 |
|
Nitroglycerin
Notes |
Dec Preload, dilate coronary arteries, fast on/fast off
Antihypertensives Group 8 |
|
Hydralazine
Drug (trade name) |
Hydralazine
Antihypertensives Group 8 |
|
Hydralazine
Class |
Hypotensive Agent
Antihypertensives Group 8 |
|
Hydralazine
Uses |
HTN (treat HTN, ↓ BP)
Antihypertensives Group 8 |
|
Hydralazine
[ Supplied ] |
20mg in 1mL
Antihypertensives Group 8 |
|
Hydralazine
Dosing--card |
N/A
Antihypertensives Group 8 |
|
Hydralazine
Dosing--Stever |
5-20mg
Antihypertensives Group 8 |
|
Hydralazine
Caution |
Principal Arterial Dilator, Tachycardia, Headache Angina, Flushing Rash
Antihypertensives Group 8 |
|
Hydralazine
Notes |
Onset 20m (slow), Duration 6-8 hours (time to raise bp back up in give too much),↑bld flow 2 head--> headache
Antihypertensives Group 8 |
|
NMB Reversal Drugs
|
The Wake Up; Induction drugs long gone, turned gas off so that is gone too, need to get rid of NMBs; Anticholinesterase Drugs prevent the hydrolysis of Ach, and an increase [Ach] @ NMJ competes with ND NMBDs; clinical uses--reversal of Non-depol NMBDs; Mech.
of action--enzyme inhibition, pre-synaptic effects, NMJ effects; get this increase [Ach] everywhere though, so get the BLUDS effect--attenuate by using in combination w/ Anticholinergic drugs; BLUDS= bradycardia/bronchospasm, lacrimation, urination, defication, salivation; Anticholinergic Drugs used clinically most often as pre-op med, for treatment of bradycardia, for NDNMB reversal and less frequently for bronchodialation, smooth muscle relaxant, antagonist of gastric acid secretion, & to prevent N/V; work by blocking muscarinic Ach receptors activated by parasymp. NS, careful though....will cause dialation of pupils (worsens Glaucoma) and will cross placenta in pregnant woman (Cautions=Glaucoma/Parturients). (Parturient=pregnant woman) NMB Reversal Drugs Group 9 |
|
Neostigmine
Drug (trade name) |
Neostigmine
NMB Reversal Drugs Group 9 |
|
Neostigmine
Class |
Anticholinesterase
NMB Reversal Drugs Group 9 |
|
Anticholinesterase
|
A substance that blocks the activity of the enzyme cholinesterase, increasing the concentration of acetylcholine in the body.
An _____ inhibitor or _____ is a chemical that inhibits the cholinesterase enzyme from breaking down ACh, increasing both the level and duration of action of the neurotransmitter acetylcholine. |
|
Neostigmine
Uses |
NMB REVERSAL
NMB Reversal Drugs Group 9 |
|
Neostigmine
[ Supplied ] |
1mg/ml or 0.5 mg/ml
NMB Reversal Drugs Group 9 |
|
Neostigmine
Dosing--card |
0.04mg/kg
NMB Reversal Drugs Group 9 |
|
Neostigmine
Dosing--Stever |
0.04-0.07mg/kg
NMB Reversal Drugs Group 9 |
|
Neostigmine
Caution |
BLUDS , Hypotension
NMB Reversal Drugs Group 9 |
|
Neostigmine
Notes |
NMB Reversal Drugs
Group 9 |
|
Glycopyrrolate
Drug (trade name) |
Glycopyrrolate (Robinol)
NMB Reversal Drugs Group 9 |
|
Glycopyrrolate
Class |
Anticholinergic
NMB Reversal Drugs Group 9 |
|
Anticholinergic
|
Blocking nerve impulses that are part of the stress response
|
|
Glycopyrrolate
Uses |
Antisialigogue, accompany NMB Reversal to fight BLUDS
NMB Reversal Drugs Group 9 |
|
Glycopyrrolate
[ Supplied ] |
0.2mg/ml
NMB Reversal Drugs Group 9 |
|
Glycopyrrolate
Dosing--card |
0.01mg/kg
NMB Reversal Drugs Group 9 |
|
Glycopyrrolate
Dosing--Stever |
premed 0.2 mg IM; Reversal 0.2mg per 1mg Neostigmine
NMB Reversal Drugs Group 9 |
|
Glycopyrrolate
Caution |
Glaucoma, Parturients
NMB Reversal Drugs Group 9 |
|
Glycopyrrolate
Notes |
good for reversal b/c don't get a big ↑ in HR
NMB Reversal Drugs Group 9 |
|
Atropine
Drug (trade name) |
Atropine
NMB Reversal Drugs Group 9 |
|
Atropine
Class |
Anticholinergic
NMB Reversal Drugs Group 9 |
|
Anticholinergic
|
An _____ agent is a substance that blocks the neurotransmitter acetylcholine in the central and the peripheral nervous system. An example of an .
is dicyclomine. . s are administered to reduce the effects mediated by acetylcholine on acetylcholine receptors in neurons through competitive inhibition. Therefore, their effects are reversible. |
|
Atropine
Uses |
Bradycardia, accompany NMB Reversal to fight BLUDS
NMB Reversal Drugs Group 9 |
|
Atropine
[ Supplied ] |
0.4, 0.5, 1mg/ml
NMB Reversal Drugs Group 9 |
|
Atropine
Dosing--card |
1.0mg vagolytic dose; 0.01mg/kg NMB reversal
NMB Reversal Drugs Group 9 |
|
Atropine
Dosing--Stever |
IM 0.01-0.02 mg/kg (up to 0.4-0.6 mg); Bradycardia 0.4-0.6mg (up to 3mg)
NMB Reversal Drugs Group 9 |
|
Atropine
Caution |
Glaucoma, Parturients
NMB Reversal Drugs Group 9 |
|
Atropine
Notes |
NMB Reversal Drugs
Group 9 |
|
Antiemetics
|
Prevention of PONV--common side effect of surgery, esp.
in pts having gyn, GU, eye/ear, or laproscopic surgery…also worse in women/young ppl. || Antiemetics Group 10 |
|
Antiemetics
|
|
|
Ondansetron
Drug (trade name) |
Ondansetron (Zofran)
Antiemetics Group 10 |
|
Ondansetron
Class |
Serotonin receptor antagonist
Antiemetics Group 10 |
|
Serotonin receptor antagonist
|
Nausea treatment. A _____n _____t acts to inhibit the action at _____n _____s.
Many of the most important medications of this class selectively act at the 5-HT3 receptor, and thus are known as 5-HT3 antagonists. However, other drugs such as ketanserin act upon other types of _____n _____s. Antagonists of the 5-HT2A receptor are sometimes used as atypical antipsychotics, with the Typical antipsychotics being purely Dopamine antagonists. |
|
Ondansetron
Uses |
Antiemetic
Antiemetics Group 10 |
|
Ondansetron
[ Supplied ] |
4mg/2mL vial
Antiemetics Group 10 |
|
Ondansetron
Dosing--card |
4mg
Antiemetics Group 10 |
|
Ondansetron
Dosing--Stever |
same
Antiemetics Group 10 |
|
Ondansetron
Caution |
Antiemetics
Group 10 |
|
Ondansetron
Notes |
1x dose, give 30m prior to end of case
Antiemetics Group 10 |
|
Doperidol
Drug (trade name) |
Doperidol (Inapsine
Antiemetics Group 10 |
|
Doperidol
Class |
Antidopaminergic
Antiemetics Group 10 |
|
Antidopaminergic
|
Preventing or counteracting the effects of dopamine.
A drug which blocks dopamine receptors by receptor antagonism. There are five known types of dopamine receptors in the human body; they are found in the brain, peripheral nervous system, blood vessels, and the kidney. |
|
Doperidol
Uses |
Antiemetic
Antiemetics Group 10 |
|
Doperidol
[ Supplied ] |
0.3125 mg/ml
Antiemetics Group 10 |
|
Doperidol
Dosing--card |
0.625 mg
Antiemetics Group 10 |
|
Doperidol
Dosing--Stever |
same
Antiemetics Group 10 |
|
Doperidol
Caution |
Parkinson's Disease, Prolonged QT interval (can cause arrhythmias), Elderly (euphoria)
Antiemetics Group 10 |
|
Doperidol
Notes |
1x dose, give 30m prior to end of case; works on Dopamine Receptors, so contraindicated in Parkinson pt
Antiemetics Group 10 |
|
Local Anesthetics
|
Transient loss of sensory, motor, and autonomic function in a discrete portion of the body; reversible conduction of blockade of impulses along central and peripheral nerve pathways; Divided into Amides and Esters; Amides ( I b4 caine) metabolized by liver & Esters (no i b4 caine) metabolized in plasma via plasma cholinesterases, also will cause allergic Rxn in ppl allergic to PABA in sunscreen.
Note that Vasoconstrictors (i.e. Epinephrine) increase duration of action of local anesthetic by limiting systemic absorption and maintaining the drug [c] at the nerve. It also decreases possibility of systemic toxicity and has little effect on onset (use 5mcg/ml or 1:200,000 Epi w/ local anesthetic); Symptoms of Toxicity: Circumoral numbness (lips), Tinnitus (ringing in ears), taste pennies, lightheadedness, visual disturbances, muscular twitching, unconsciousness, convulsions, respiratory depression, cardiovascular collapse (described w/ increasing levels of toxicity);PVC=premature ventricular contraction; Infiltration=using lidocaine to numb area b4 giving IV/creating wheal under skin; use nebulizer to numb airway for awake intubation; use at induction to attenuate burning on injection of induction drugs; IV regional anesthesia (IVRA) = Bier Block; Peripheral Nerve Block (PNB) = ankle or femural block; . || Local Anesthetics Group 11 |
|
Local Anesthetics
|
An anesthetic that causes loss of sensation only to the area to which it is applied.
A local anesthetic is a drug that causes reversible local anesthesia and a loss of nociception. When it is used on specific nerve pathways (nerve block), effects such as analgesia (loss of pain sensation) and paralysis (loss of muscle power) can be achieved. |
|
Lidocaine
Drug (trade name) |
Lidocaine
Local Anesthetics Group 11 |
|
Lidocaine
Class |
Amide
Local Anesthetics Group 11 |
|
Amide
|
In chemistry, amide usually refers to organic compounds that contain the functional group consisting of an acyl group (C=O) linked to a nitrogen atom (N).
The term refers both to a class of compounds and a functional group within those compounds. The term amide also refers to deprotonated form of ammonia (NH3) or an amine, often represented as anions R2N-. |
|
Lidocaine
Uses |
local anesthesia, cough, inhalation
Local Anesthetics Group 11 |
|
Lidocaine
[ Supplied ] |
0.5-5%
Local Anesthetics Group 11 |
|
Lidocaine
Dosing--card |
1mg/kg IV
Local Anesthetics Group 11 |
|
Lidocaine
Dosing--Stever |
Topical (4%); Infiltration (0.5-1%); IVRA (0.25-0.5%); PNB (1-1.5%); Epidural (1.5-2%); Spinal (1.5-5%)
Local Anesthetics Group 11 |
|
Lidocaine
Caution |
Hepatic Disease (metab.
In liver) Local Anesthetics Group 11 |
|
Lidocaine
Notes |
Hepatic Clearance
Toxic Dose: 5mg/kg alone 7 mg/kg with Epi Local Anesthetics Group 11 |
|
Diphenhydramine
Drug (trade name) |
Diphenhydramine (Benadryl)
Other Drugs--from orange card Group 12 |
|
Diphenhydramine
Class |
H1 Antagonist
Other Drugs--from orange card Group 12 |
|
H1 Antagonist
|
A histamine antagonist of the H1 receptor that serves to reduce or eliminate effects mediated by histamine, an endogenous chemical mediator released during allergic reactions.
Agents where the main therapeutic effect is mediated by negative modulation of histamine receptors are termed antihistamines—other agents may have antihistaminergic action but are not true antihistamines. |
|
Diphenhydramine
Uses |
antihistamine
Other Drugs--from orange card Group 12 |
|
Diphenhydramine
[ Supplied ] |
50 mg/ml
Other Drugs--from orange card Group 12 |
|
Diphenhydramine
Dosing--card |
25mg (12.5-50)
Other Drugs--from orange card Group 12 |
|
Diphenhydramine
Dosing--Stever |
Other Drugs--from orange card
Group 12 |
|
Diphenhydramine
Caution |
causes sedation
Other Drugs--from orange card Group 12 |
|
Diphenhydramine
Notes |
Hepatic Elimination
Other Drugs--from orange card Group 12 |
|
Heparin
Drug (trade name) |
Heparin
Other Drugs--from orange card Group 12 |
|
Heparin
Class |
Anticoagulant
Other Drugs--from orange card Group 12 |
|
Anticoagulant
|
A substance that prevents coagulation; that is, it stops blood from clotting.
Any of a group of drugs that suppress, delay, or prevent clots (masses of blood cells) from forming in the bloodstream. Also known as blood thinners, anticoagulants are used to treat heart, lung, or blood vessel disorders. The drug may be administered for a heart attack, pulmonary embolism (blockage of the artery that feeds the lung), or irregular heartbeat, which may cause harmful clots to form. |
|
Heparin
Uses |
Anticoagulant
Other Drugs--from orange card Group 12 |
|
Heparin
[ Supplied ] |
varrying conc.
|| Other Drugs--from orange card Group 12 |
|
Heparin
Dosing--card |
det.
By surgeon Other Drugs--from orange card Group 12 |
|
Heparin
Dosing--Stever |
Other Drugs--from orange card
Group 12 |
|
Heparin
Caution |
occular/intracranial sg, spinal/epidural
Other Drugs--from orange card Group 12 |
|
Heparin
Notes |
Hepatic Elimination
Other Drugs--from orange card Group 12 |
|
Ketorolac
Drug (trade name) |
Ketorolac (Toradol)
Other Drugs--from orange card Group 12 |
|
Ketorolac
Class |
NSAID
Other Drugs--from orange card Group 12 |
|
NSAID or NAIDs
|
Non-steroidal anti-inflammatory drugs have analgesic, antipyretic (lowering an elevated body temperature and relieving pain without impairing consciousness) and, in higher doses, with anti-inflammatory.
The term "non-steroidal" is used to distinguish these drugs from steroids, which have a similar eicosanoid-depressing, anti-inflammatory action. As analgesics, NSAIDs are unusual in that they are non-narcotic. |
|
Ketorolac
Uses |
Anti-inflammatory
Other Drugs--from orange card Group 12 |
|
Ketorolac
[ Supplied ] |
30 mg/ml
Other Drugs--from orange card Group 12 |
|
Ketorolac
Dosing--card |
30mg (15-60) IV or IM
Other Drugs--from orange card Group 12 |
|
Ketorolac
Dosing--Stever |
Other Drugs--from orange card
Group 12 |
|
Ketorolac
Caution |
Renal pt, may cause bleeding, ↓ platelet fx, nausea
Other Drugs--from orange card Group 12 |
|
Ketorolac
Notes |
Renal Clearance, Postop Analgesic; avoid w/ NSAID Allergy or recent hx GI bleeding
Other Drugs--from orange card Group 12 |